Mar 29, 2023 08:00 AM

Tasly Pharmaceutical Group Co.,Ltd. Posted 340.8 Million Yuan Net Loss in 2022

By Caixin Automation

Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) (600535.SH) reported a net loss of 340.8 million yuan in 2022, reversing a net profit of 2.4 billion yuan for the previous year.

Meanwhile, the company posted 8.6 billion yuan in revenue, up 8.1% year-on-year.

At the end of the reporting period, it had 16.4 billion yuan in total assets and 3.8 billion yuan in total liabilities, with a liability-to-asset ratio of 22.9%.

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Innovation Takes Off at Flying Vehicle Expo

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

Caixin Deep Dive: How China’s Crypto Ban Makes Disposing of Seized Assets a Lot Harder

00:00

00:00/00:00

MOST POPULAR

1: Cover Story: China’s Factory Exodus Is Turning Vietnam Into the World’s Assembler

2: Meituan Enters Open-Source AI Race With LongCat Model

3: Ex-UBS Banker in Hong Kong Jailed 10 Years for Laundering $17.2 Million

4: End of U.S. Tax Exemption Hits Chinese Air Cargo Carriers Differently

5: Alipay Fined by Luxembourg Regulator for Anti-Money Laundering Breaches

SPONSORED

OR